Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
51	51 Erasca ERAS $456M	243% upside 3 price targets	0
52	52 Solid Biosciences SLDB $357M	241% upside 7 price targets	0
53	53 Perspective Therapeutics CATX $255M	240% upside 5 price targets	0
54	54 Arrowhead Research ARWR $2.34B	238% upside 3 price targets	0
55	55 PolyPid PYPD $36M	233% upside 4 price targets	0
56	56 Nuvation Bio NUVB $582M	231% upside 3 price targets	0
57	57 Corvus Pharmaceuticals CRVS $328M	230% upside 3 price targets	0
58	58 Dyne Therapeutics DYN $1.23B	224% upside 5 price targets	0
59	59 Absci ABSI $346M	223% upside 4 price targets	0
60	60 Trevi Therapeutics TRVI $793M	222% upside 5 price targets	0
61	61 Taysha Gene Therapies TSHA $683M	222% upside 5 price targets	0
62	62 Cullinan Oncology CGEM $533M	217% upside 3 price targets	0
63	63 Vera Therapeutics VERA $1.44B	214% upside 4 price targets	0
64	64 Coya Therapeutics COYA $94.2M	213% upside 3 price targets	0
65	65 Viking Therapeutics VKTX $2.97B	213% upside 5 price targets	0
66	66 Syndax Pharmaceuticals SNDX $967M	211% upside 3 price targets	0
67	67 Immunome IMNM $833M	210% upside 4 price targets	0
68	68 Abeona Therapeutics ABEO $330M	208% upside 4 price targets	0
69	69 uniQure QURE $810M	207% upside 3 price targets	0
70	70 EyePoint Pharmaceuticals EYPT $634M	192% upside 4 price targets	0
71	71 Knightscope KSCP $42.8M	191% upside 3 price targets	0
72	72 W.P. Carey WPC $13.9B	188% upside 3 price targets	0
73	AARD 73 Aardvark Therapeutics, Inc. Common Stock AARD $255M	184% upside 3 price targets	0
74	BCYC 74 Bicycle Therapeutics BCYC $598M	181% upside 6 price targets	0
75	75 Y-mAbs Therapeutics YMAB $231M	178% upside 3 price targets	0

12345

65